JP2023516713A5 - - Google Patents

Info

Publication number
JP2023516713A5
JP2023516713A5 JP2022552880A JP2022552880A JP2023516713A5 JP 2023516713 A5 JP2023516713 A5 JP 2023516713A5 JP 2022552880 A JP2022552880 A JP 2022552880A JP 2022552880 A JP2022552880 A JP 2022552880A JP 2023516713 A5 JP2023516713 A5 JP 2023516713A5
Authority
JP
Japan
Prior art keywords
ep402r
gene
asf virus
attenuated
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022552880A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023516713A (ja
Filing date
Publication date
Priority claimed from GBGB2003292.6A external-priority patent/GB202003292D0/en
Priority claimed from GBGB2003289.2A external-priority patent/GB202003289D0/en
Priority claimed from GBGB2005880.6A external-priority patent/GB202005880D0/en
Priority claimed from GBGB2005878.0A external-priority patent/GB202005878D0/en
Priority claimed from GBGB2013541.4A external-priority patent/GB202013541D0/en
Application filed filed Critical
Priority claimed from PCT/GB2021/050562 external-priority patent/WO2021176236A1/en
Publication of JP2023516713A publication Critical patent/JP2023516713A/ja
Publication of JP2023516713A5 publication Critical patent/JP2023516713A5/ja
Pending legal-status Critical Current

Links

JP2022552880A 2020-03-06 2021-03-05 アフリカ豚熱ウイルス感染に対するワクチン Pending JP2023516713A (ja)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
GB2003292.6 2020-03-06
GB2003289.2 2020-03-06
GBGB2003292.6A GB202003292D0 (en) 2020-03-06 2020-03-06 Vaccine
GBGB2003289.2A GB202003289D0 (en) 2020-03-06 2020-03-06 Vaccine
GBGB2005880.6A GB202005880D0 (en) 2020-04-22 2020-04-22 Vaccine
GB2005878.0 2020-04-22
GBGB2005878.0A GB202005878D0 (en) 2020-04-22 2020-04-22 Vaccine
GB2005880.6 2020-04-22
GBGB2013541.4A GB202013541D0 (en) 2020-08-28 2020-08-28 Vaccine
GB2013541.4 2020-08-28
PCT/GB2021/050562 WO2021176236A1 (en) 2020-03-06 2021-03-05 Vaccine against african swine fever virus infection

Publications (2)

Publication Number Publication Date
JP2023516713A JP2023516713A (ja) 2023-04-20
JP2023516713A5 true JP2023516713A5 (cg-RX-API-DMAC7.html) 2024-03-11

Family

ID=74870840

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022552880A Pending JP2023516713A (ja) 2020-03-06 2021-03-05 アフリカ豚熱ウイルス感染に対するワクチン
JP2022552870A Pending JP2023516709A (ja) 2020-03-06 2021-03-05 アフリカ豚熱ウイルス感染に対するワクチン

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022552870A Pending JP2023516709A (ja) 2020-03-06 2021-03-05 アフリカ豚熱ウイルス感染に対するワクチン

Country Status (13)

Country Link
US (3) US20240293525A1 (cg-RX-API-DMAC7.html)
EP (3) EP4114454A1 (cg-RX-API-DMAC7.html)
JP (2) JP2023516713A (cg-RX-API-DMAC7.html)
KR (2) KR20230013017A (cg-RX-API-DMAC7.html)
CN (3) CN116133680A (cg-RX-API-DMAC7.html)
AU (2) AU2021231402A1 (cg-RX-API-DMAC7.html)
BR (2) BR112022016893A8 (cg-RX-API-DMAC7.html)
CA (2) CA3170058A1 (cg-RX-API-DMAC7.html)
CL (2) CL2022002412A1 (cg-RX-API-DMAC7.html)
CO (2) CO2022014152A2 (cg-RX-API-DMAC7.html)
MX (2) MX2022010372A (cg-RX-API-DMAC7.html)
PH (2) PH12022552084A1 (cg-RX-API-DMAC7.html)
WO (3) WO2021176234A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201910794D0 (en) * 2019-07-29 2019-09-11 Pirbright Inst Vaccine
EP4565269A2 (en) * 2022-08-04 2025-06-11 Malcolm, Thomas Dominant negative antigen approach for prophylactic and post-infection treatment of swine against african swine fever virus
WO2024057048A1 (en) * 2022-09-12 2024-03-21 Consejo Superior De Investigaciones Científicas Attenuated african swine fever virus and use thereof in vaccine compositions
CN120936878A (zh) * 2022-11-22 2025-11-11 马德里黄金标准诊断公司 用于区分感染asfv与asfv疫苗接种的动物的方法
CN120897756A (zh) * 2022-11-22 2025-11-04 英特维特国际股份有限公司 减毒非洲猪瘟病毒及其在疫苗组合物中的用途
CN117224669B (zh) * 2023-07-31 2024-07-30 中国农业科学院兰州兽医研究所 非洲猪瘟病毒mgf360-21r蛋白作为免疫诱导剂或者佐剂的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015091322A1 (en) * 2013-12-18 2015-06-25 Boehringer Ingelheim Vetmedica Gmbh Cd2 deficient african swine fever virus as live attenuated or subsequently inactivated vaccine against african swine fever in mammals
GB201410971D0 (en) * 2014-06-19 2014-08-06 Pirbright Inst The Vaccine
US9528094B2 (en) * 2014-11-10 2016-12-27 The United States Of America, As Represented By The Secretary Of Agriculture Attenuated African swine fever virus vaccine based in the deletion of MGF genes
CN110551695A (zh) * 2019-08-14 2019-12-10 中国农业科学院上海兽医研究所(中国动物卫生与流行病学中心上海分中心) 非洲猪瘟病毒四基因缺失弱毒株及其应用

Similar Documents

Publication Publication Date Title
JP2023516709A5 (cg-RX-API-DMAC7.html)
Gane et al. Evaluation of RNAi therapeutics VIR-2218 and ALN-HBV for chronic hepatitis B: results from randomized clinical trials
Streicher Exploring the future of infectious disease treatment in a post-antibiotic era: A comparative review of alternative therapeutics
Cantin et al. Gamma interferon (IFN-γ) receptor null-mutant mice are more susceptible to herpes simplex virus type 1 infection than IFN-γ ligand null-mutant mice
JP2022051775A5 (cg-RX-API-DMAC7.html)
JP2019508045A5 (cg-RX-API-DMAC7.html)
JP2016538885A5 (cg-RX-API-DMAC7.html)
JP2006518372A5 (cg-RX-API-DMAC7.html)
JP2021520203A5 (cg-RX-API-DMAC7.html)
Klavinskis et al. Cytotoxic T lymphocyte control of acute lymphocytic choriomeningitis virus infection: interferon γ, but not tumour necrosis factor α, displays antiviral activity in vivo
KR20180081616A (ko) 항-vegf로 치료된 연령-관련 황반 변성을 앓고 있는 환자에서의 임상 결과와 유전적 변이체를 연관시키는 방법
JP2023504773A5 (cg-RX-API-DMAC7.html)
Dar et al. CpG-ODNs induced changes in cytokine/chemokines genes expression associated with suppression of infectious bronchitis virus replication in chicken lungs
JP2018532428A5 (cg-RX-API-DMAC7.html)
Xu et al. Differential modulation of avian β-defensin and Toll-like receptor expression in chickens infected with infectious bronchitis virus
JP2021500016A5 (cg-RX-API-DMAC7.html)
JP2019523648A5 (cg-RX-API-DMAC7.html)
US20230124042A1 (en) Vaccine against african swine fever virus infection
Park et al. Protection of chicken against very virulent IBDV provided by in ovo priming with DNA vaccine and boosting with killed vaccine and the adjuvant effects of plasmid-encoded chicken interleukin-2 and interferon-γ
CA3242351A1 (en) Methods and compositions for treating bag-3 related cardiomyopathy with a viral vector
JP2020503265A5 (cg-RX-API-DMAC7.html)
RU2018142174A (ru) Контролируемая пищевым рационом экспрессия нуклеиновой кислоты, кодирующей нуклеазу cas9, и ее применения
CA3242262A1 (en) Methods and compositions for treating mybpc3 related hypertrophic cardiomyopathy with a viral vector
CN1455674A (zh) 绵羊副痘病毒菌株用于制备抗病毒药物和抗癌药物的用途
Zhang et al. Possible modulation by male sex hormone of Th1/Th2 function in protection against Plasmodium chabaudi chabaudi AS infection in mice